Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Saudi Dent J ; 36(2): 301-307, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38419990

ABSTRACT

Background: To investigate the short-term dentoalveolar effects on the mandibular arch of a modified, aesthetic lip bumper (ALBAa). The study sample comprised 23 patients (13 boys and 10 girls, with a mean age of 9.5 ± 1.8 years) in mixed dentition, with no previous orthodontic treatment. For each patient, a scan of the mandibular arch was digitally acquired pre-treatment (T0), and at 3 months (T1), 6 months (T2) and 9 months (T3) post-treatment. Linear intra-arch measurements, Little's irregularity index of the amount of mandibular anterior crowding, and the crown tipping values on all mandibular teeth were measured and compared statistically between time points. ANOVA and subsequent post-hoc tests were performed, considering a p-value of < 0.05 as significant. Results: Linear intra-arch distances and crown tipping values on the mandibular teeth increased between the following time points: T0vsT1, T1vsT2, T0vsT2 and T0vsT3 (p < 0.05), although in the last three months of observation (T2vsT3) they only reached statistical significance at the lower incisors and lower left premolar concerning crown tipping values. There was a statistically significant decrease in anterior crowding throughout the observational period (p < 0.05), and this effect was equally distributed across the different time points investigated. Conclusions: ALBAa therapy led to an increase in both linear intra-arch distances and crown tipping values, with a reduction in Little's index. The distribution of the effects reported across the observational period depended on the mechanism of action (mechanical vs. functional).

2.
J Pediatr Urol ; 14(1): 68.e1-68.e6, 2018 02.
Article in English | MEDLINE | ID: mdl-29133170

ABSTRACT

INTRODUCTION: Ureteropelvic junction obstruction (UPJO) is one of the most frequent urological diseases affecting the pediatric population. It can be due to both intrinsic stenosis of the junction and extrinsic causes such as the presence of crossing vessels (CVs), which can be detected by color Doppler ultrasound (CD-US). Magnetic resonance urography (MRU) is a good alternative, but sedation and infusion of a contrast agent are required. OBJECTIVE: The aim of this study was to analyze the diagnostic accuracy of CD-US and MRU in visualizing CVs in pediatric hydronephrosis, in order to decide the correct diagnostic pathway in the pre-operative phase. MATERIAL AND METHODS: A retrospective review was performed of medical records for all patients who underwent surgical treatment for hydronephrosis from August 2006 to February 2016. Ultrasound and scintigraphy had been performed on all patients. Data about CD-US and MRU were collected. A high-level technology ultrasound scanner and a 1.5 T MR scanner were used. The presence of CVs at surgery was considered the gold standard. Sensitivity, specificity, positive and negative predictive values (NPV) were calculated and reported for both of the imaging techniques. RESULTS: A total of 220 clinical charts were reviewed. Seventy-three CVs were identified at surgery (33.2% of UPJO). The median age was statistically higher in the group with CVs compared to the group without CVs (P < 0.001). The sensitivity and NPV of CD-US in detecting CVs were higher than MRU (sensitivity 93.3% vs. 71.7%, NPV 95.7% vs. 77.6%, respectively). DISCUSSION: According to the data, CD-US had higher sensitivity and NPV than MRU, resulting in superior detection of CVs. It is important for a surgeon to know that a child has a CV, especially in older children in which the incidence of extrinsic UPJO is higher. The main limitation of this study was the presence of incomplete data, due to the retrospectivity. CONCLUSIONS: In the pre-operative phase, the CD-US should be considered as the investigation of choice to detect CVs in children with hydronephrosis (Summary Fig). Moreover, CD-US has lower costs than MRU, and sedation with infusion of contrast agent is unnecessary. For the future, it could be useful to lead a prospective comparison between the two imaging techniques.


Subject(s)
Hydronephrosis/congenital , Hydronephrosis/diagnostic imaging , Magnetic Resonance Imaging/methods , Multicystic Dysplastic Kidney/diagnostic imaging , Ultrasonography, Doppler, Color/methods , Ureteral Obstruction/diagnostic imaging , Urography/methods , Adolescent , Child , Child, Preschool , Cohort Studies , Critical Pathways , Female , Humans , Hydronephrosis/physiopathology , Hydronephrosis/surgery , Male , Multicystic Dysplastic Kidney/surgery , Predictive Value of Tests , Preoperative Care/methods , Retrospective Studies , Risk Assessment , Sensitivity and Specificity , Statistics, Nonparametric , Ureteral Obstruction/surgery
3.
Infection ; 34(1): 9-16, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16501896

ABSTRACT

BACKGROUND: Nosocomial bacterial pneumonia (NBP) was once considered a common cause of morbidity and mortality among advanced AIDS patients. However, clinical and microbiological characteristics and outcome-associated risk factors in this population are poorly defined. PATIENTS: We conducted a retrospective study of all HIV-infected patients admitted during the period 1988-2002 at the Infectious Diseases Clinic of Milan, Italy, to determine incidence rate and factors affecting mortality of NBP, and to gather clinical and microbiological findings about the condition. RESULTS: We identified 120 episodes of NBP among 4,967 admissions of HIV-infected individuals. A reduction of incidence became evident after the introduction of highly active antiretroviral therapy (HAART). The more common causative agents were Pseudomonas aeruginosa (33%) Staphylococcus aureus (25%) and Streptococcus pneumoniae (21%). Methicillin resistance was frequent among staphylococci (65%). The mortality rate of NBP was 25.8%. Non-statistically significant factors associated with shorter survival were: CD4(+) count < 10 cells/microl, concomitant lung neoplasm, and complicated roentgenographic picture. Only one factor was significantly associated with lower survival, both in univariate and multivariate analysis: a methicillin-resistant Staphylococcus serving as an etiologic agent of pneumonia (RR 4.05; 95% CI, 1.076-15.239; p = 0.039). CONCLUSION: A decline in incidence of NBP in HIV-infected individuals was observed after introduction of HAART. S. aureus and P. aeruginosa were the leading causes of NBP, but frequency of pneumococcal pneumonia was significant. The sole predictor for mortality was methicillin-resistant Staphylococcus as a pneumonia-causing agent.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cross Infection/microbiology , Cross Infection/mortality , HIV Infections/complications , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/mortality , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/microbiology , AIDS-Related Opportunistic Infections/mortality , Adult , Anti-Bacterial Agents/pharmacology , Antiretroviral Therapy, Highly Active , Cross Infection/drug therapy , Cross Infection/epidemiology , Female , HIV Infections/drug therapy , Humans , Incidence , Male , Methicillin Resistance , Microbial Sensitivity Tests , Middle Aged , Pneumonia, Bacterial/drug therapy , Pneumonia, Bacterial/epidemiology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , Risk Factors , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/isolation & purification , Survival Analysis
4.
Assist Inferm Ric ; 19(2): 112-9, 2000.
Article in Italian | MEDLINE | ID: mdl-11107366

ABSTRACT

Care of central venous catheter (CVC) in patients undergoing bone marrow transplantation (BMT) raises significant problems related to the high risk of local infections, to the immunodeficient status, which in itself is a predisposing factor for systematic blood stream infections. Although frequent changes of CVC dressing might theoretically reduce the incidence of infections, they are also accompanied by significant skin toxicity and patient discomfort. No study has yet addressed these points. The objective of this study was to compare two different time interval protocols for CVC dressing, in order to assess the effects on local infections and toxicity. In a multicentre study, 339 bone marrow transplant (BMT) patients with a tunnelled CVC (group A, 230 pts) or a non tunnelled one (Group B, 169 patients) were randomly allocated to receive CVC dressing changes every 5 or 10 days if belonging to group A or 2 or 5 days if in group B. Transparent impermeable polyurethane dressings were used for all patients. The rate of local infection at the site of CVC insertion was assessed by microbiological assay every 10 days, while severity of skin toxicity was measured according to the ECOG scale. Sixty-five per cent of enrolled patients were finally evaluable. Patients (in both groups) receiving CVC dressing changes at longer intervals did not show a significant increase in the rate of local infections, while those who received dressing every two days had a significant increase in local skin toxicity. Longer intervals were accompanied by a reduction in costs. The results of this study demonstrate that the increase in time interval between CVC dressing changes in BMT patients did not increment the risk of local infections, while significantly reducing patients discomfort and costs.


Subject(s)
Bone Marrow Transplantation , Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/nursing , Infection Control/methods , Skin Care/methods , Skin Care/nursing , Clinical Nursing Research , Clinical Protocols , Drug Therapy/methods , Drug Therapy/nursing , Humans , Nursing Assessment , Time Factors
5.
Haematologica ; 85(3): 275-9, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10702816

ABSTRACT

BACKGROUND AND OBJECTIVE: Care of central venous catheter (CVC) in patients undergoing bone marrow transplantation (BMT) raises significant problems related to the high risk of local infections due to the immunodeficient status, which in itself is a predisposing factor for systemic blood-stream infections. Although frequent changes of CVC dressing might theoretically reduce the incidence of infections, they are also accompanied by significant skin toxicity and patient discomfort. No study has yet addressed these points. The objective of this study was to compare two different time interval protocols for CVC dressing in order to assess the effects on local infections and toxicity. DESIGN AND METHODS: In a multicenter study, 399 bone marrow transplant (BMT) patients with a tunneled CVC (Group A, 230 pts) or a non-tunneled one (Group B, 169 pts) were randomly allocated to receive CVC dressing changes every 5 or 10 days, if belonging to Group A, or 2 or 5 days, if in Group B. Transparent, impermeable polyurethane dressings were used for all patients. The rate of local infections at the site of CVC insertion was assessed by microbiological assays every 10 days, while the severity of skin toxicity was measured according to the ECOG scale. RESULTS: Sixty-five per cent of enrolled patients were finally evaluable. Patients (in both Groups) receiving CVC dressing changes at longer intervals did not show a significant increase in the rate of local infections, while those who received dressing every 2 days had a significant increase in local skin toxicity. Longer intervals were accompanied by a reduction in costs. INTERPRETATION AND CONCLUSIONS: The results of this study demonstrate that the increase in time interval between CVC dressing changes in BMT patients did not raise the risk of local infections, while significantly reducing patient discomfort and costs.


Subject(s)
Bone Marrow Transplantation , Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/methods , Bone Marrow Transplantation/adverse effects , Bone Marrow Transplantation/economics , Catheterization, Central Venous/economics , Costs and Cost Analysis , Dermatitis/etiology , Exanthema/etiology , Humans , Infection Control/methods , Infections/etiology , Time Factors
6.
Clin Infect Dis ; 29(3): 553-60, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10530447

ABSTRACT

Among 324 cases of culture-proven tuberculosis from 1988 to 1996 in a hospital in Milan, Italy, 90 (27.8%) were due to Mycobacterium tuberculosis strains resistant to isoniazid and rifampin. Sixty-one of 69 isolates tested had identical restriction fragment length polymorphism patterns. The prevalent strain tested susceptible only to ethionamide and was also resistant to ethambutol, streptomycin, cycloserine, amikacin, kanamycin, terizodone, ofloxacin, rifabutin, rifapentin, and KRM 1648. The median survival time was 94 days. Multivariate analysis showed a trend toward better outcome in the period 1994-1996 (hazard ratio, 4.16; P<.001), and extrapulmonary localization of tuberculosis was the only other independent predictor of a negative outcome (hazard ratio, 2.1; P = .019). The delay from symptoms to beginning of therapy did not seem to be a determining factor in survival time. Standard antituberculosis therapy with four drugs (isoniazid, rifampin, ethambutol, and pyrazinamide) had a higher efficacy than did other regimens with fewer drugs but without a statistically significant difference.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/mortality , Antitubercular Agents/therapeutic use , Drug Resistance, Multiple , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/mortality , AIDS-Related Opportunistic Infections/diagnosis , Adult , Analysis of Variance , Cross Infection/diagnosis , Cross Infection/drug therapy , Cross Infection/mortality , Female , Hospitals/statistics & numerical data , Humans , Italy/epidemiology , Male , Microbial Sensitivity Tests , Middle Aged , Polymerase Chain Reaction , Proportional Hazards Models , Survival Analysis , Survival Rate , Treatment Outcome , Tuberculosis, Multidrug-Resistant/diagnosis
7.
Assist Inferm Ric ; 18(1): 14-9, 1999.
Article in Italian | MEDLINE | ID: mdl-10969553

ABSTRACT

Central Venous Catheters (CVC) are widely used in the setting of intensive care units, but they are associated with an increased risk of CVC-related infections. To prevent infections originated from CVC, a number of devices have been more recently produced, that are characterized by the presence of antiseptic/antibiotic substances in the matrix of the CVC itself ("impregnated" CVC). In this brief review, more recent studies on the topic are discussed, especially in the light of guidelines from the CDC. Although from these studies many suggestions about the efficacy of impregnated CVC in the prevention of CVC-related infections can be derived, notwithstanding the critical role of preventive measures during CVC procedures must be recognized as the principal factor in reducing CVC infections.


Subject(s)
Anti-Bacterial Agents , Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/instrumentation , Catheters, Indwelling/adverse effects , Catheters, Indwelling/supply & distribution , Coated Materials, Biocompatible/supply & distribution , Centers for Disease Control and Prevention, U.S. , Critical Care , Cross Infection/etiology , Cross Infection/prevention & control , Equipment Contamination/prevention & control , Humans , Infection Control/methods , Practice Guidelines as Topic , United States
8.
Nephrol Dial Transplant ; 11(9): 1803-9, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8918626

ABSTRACT

Peritoneal fibrosis in patients on peritoneal dialysis is the result of interstitial collagen accumulation within the peritoneal membrane and in mural spaces. Hypothetically, collagen expression by target cells may be regulated by specific endoperitoneal factors, though the existence of such factors has not yet been demonstrated. We evaluated the effects of cell-free peritoneal effluents obtained from six children undergoing peritoneal dialysis on several mesothelial cell functions in vitro. Human peritoneal mesothelial cells (MC) were obtained from the omental tissue of six uraemic children who were undergoing surgery for insertion of a peritoneal catheter. Cells at confluence were utilized to determine cytotoxicity (LDH release), viability (trypan blue), proliferation (3H-thymidine incorporation), collagen expression (3H-proline incorporation, SDS-Page) and mRNA (dot-blot). A preliminary series of experiments, was undertaken to define which of the successive fluid collections during a dialytic procedures induces the greatest changes; this revealed maximal effects of the effluent from the long stasis period. Exposure to peritoneal effluents obtained from four patients with acute peritonitis induced marked changes in cell morphology, stimulated by (3H)-thymidine incorporation into DNA by 300% and upregulated the expression and transcription of type III collagen (6-fold increment in COL3A1 mRNA). Qualitatively but not quantitatively comparable changes in cell proliferation (+100%) and collagen expression were induced by peritoneal effluents from patients without peritonitis. In an effort to reproduce the effect of peritoneal effluents in vitro, we exposed mesothelial cells to various cytokines putatively present in infected peritoneal effluents, namely IL-2, TGF beta and TNF alpha; in no case did we find stimulation of cell proliferation. Finally TGF beta but not TNF alpha or IL2 upregulated collagen synthesis by these cells. These findings demonstrate a direct influence of cell-free peritoneal effluents on mesothelial cell functions, including stimulation of interstitial collagen expression. All these changes were more evident upon exposure to effluents collected during acute peritonitis, which suggests a link between recurrent peritoneal infection and collagen deposition, the most typical precursor of peritoneal fibrosis.


Subject(s)
Peritoneal Dialysis/adverse effects , Peritoneum/pathology , Adolescent , Ascitic Fluid/metabolism , Cell Division/drug effects , Cells, Cultured , Child , Collagen/biosynthesis , Collagen/genetics , Epithelium/drug effects , Epithelium/metabolism , Epithelium/pathology , Extracellular Matrix/metabolism , Fibrosis , Humans , Interleukin-2/pharmacology , Peritoneum/drug effects , Peritoneum/metabolism , Proline/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Thymidine/metabolism , Transforming Growth Factor beta/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
9.
Clin Exp Immunol ; 101(1): 172-6, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7621585

ABSTRACT

Mesothelial cells (MC) from human peritoneal omentum fragments obtained during surgical insertion of peritoneal catheters for continuous peritoneal dialysis in end stage renal failure (ESRF) patients were cultured in vitro. MC exhibited a phenotype different from macrophages, but MHC class II molecules were well expressed. Therefore MC lines were tested for antigen-presenting capacity by pulsing with soluble antigens (tetanus toxoid and purified protein derivative (PPD)) or with a corpusculate antigen (Candida albicans bodies). Autologous peripheral blood mononuclear cells (PBMC) depleted of adherent monocytes and cloned T cells generated from an individual matched for the MHC class II antigen DR2 were used to test antigen-presenting function. MC effectively presented the soluble and corpusculate antigens to autologous and MHC-compatible allogeneic lymphocytes, indicating that they are endowed with both endocytic/phagocytic activity and with processing/presenting capacity. Preincubation of MC with human recombinant interferon-gamma (IFN-gamma) up-regulated MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression, but the effect on antigen-presenting function was not consistent. Since MC are an important component of the peritoneal environment, they may participate, along with macrophages, in activation of specific T cells and in the generation of local cell-mediated immunity to various pathogens.


Subject(s)
Antigen-Presenting Cells/physiology , Peritoneal Cavity/cytology , Adolescent , Antigen Presentation/physiology , Cell Line , Child , Child, Preschool , Epithelial Cells , Humans , Immunophenotyping/methods
10.
Radiol Med ; 84(6): 774-9, 1992 Dec.
Article in Italian | MEDLINE | ID: mdl-1494682

ABSTRACT

Renal artery stenosis (RAS) in renal transplanted pediatric patients is a long-term complication. The clinical suspicion must be considered when patients exhibit signs of impaired renal function or refractory hypertension, not associated with other complications of renal transplantation -i.e., acute or chronic rejection, glomerulonephritis, cyclosporine toxicity. The intermediate step between clinical suspicion and angiography is represented by Doppler US. The authors report their experience with Doppler US in the screening of RAS in a pediatric series of transplanted patients. The incidence of RAS in our series (54 transplanted kidneys, 46 of them included in the study) was 4.3%. A severe stenosis was demonstrated by both Doppler US and angiography in 2 patients, with 100% Doppler sensitivity. In both stenoses, Doppler US showed high systolic peaks (blood flow velocity > or = 2.5 m/s) and post-stenotic turbulence. Thanks to its high sensitivity, Doppler US is considered to be very useful in the screening of vascular complications in renal transplanted children.


Subject(s)
Kidney Transplantation/adverse effects , Renal Artery Obstruction/diagnostic imaging , Adolescent , Adult , Child , Child, Preschool , Echocardiography , Female , Humans , Male , Renal Artery Obstruction/etiology
12.
Clin Nephrol ; 32(5): 235-8, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2582649

ABSTRACT

The characterization of cellular populations in peritoneal effluents (PE) of CAPD patients has been the subject of few studies. In order to establish a possible correlation between PE cells and clinical parameters, we studied the immunocompetent cells that are found in uncomplicated patients. In this study we used cytofluorimetric analysis to characterize phenotypically immunocompetent PE cells. We studied 17 children with a mean age of 8.7 +/- 5.3 years, who had been on CAPD for a mean duration of 16 months. The patients never suffered from peritonitis. The effluents were collected after overnight dialysis and centrifuged to concentrate cells. Surface phenotype of PE cells was tested with a panel of monoclonal antibodies. The analysis of 40 PE samples showed that the various cell types were present with different frequencies, suggesting that a dominant phenotype cannot be defined. The ratio between M3 positive cells (monocytic-macrophagic lineage) and T3 positive cells (T lymphocytes) showed a tendency to decrease after initiation of CAPD. T4/T8 ratio in all samples did not differ from that of peripheral lymphocytes. A high frequency of activated T cells (41% +/- 13), defined by the presence of DR antigens on T3+ M3- cells, was seen in PE and confirmed by the high frequency of T cells expressing the IL-2 receptor.


Subject(s)
Kidney Failure, Chronic/therapy , Peritoneal Cavity/pathology , Peritoneal Dialysis, Continuous Ambulatory , Adolescent , Child , Child, Preschool , Flow Cytometry/methods , Humans , Macrophages/cytology , Monocytes/cytology , T-Lymphocytes/cytology
13.
Eur J Clin Pharmacol ; 34(1): 25-8, 1988.
Article in English | MEDLINE | ID: mdl-3282894

ABSTRACT

The safety and efficacy of a single daily dose of fenofibrate (200 mg) have been evaluated in 12 Type IIB hyperlipidaemic patients in a three-month study. At the same time the pharmacokinetics was studied to check whether this new dosage schedule would give a therapeutic plasma levels of fenofibrate. At the single daily dose of 200 mg, fenofibrate was highly effective, very well tolerated, and it reached therapeutic plasma levels without accumulation. It appears that fenofibrate can usefully be employed at this dosage in hyperlipidaemia, especially since patient compliance is better when only one daily dose need be taken.


Subject(s)
Anticholesteremic Agents/administration & dosage , Fenofibrate/administration & dosage , Hyperlipoproteinemia Type II/drug therapy , Hypolipidemic Agents/administration & dosage , Lipoproteins/blood , Propionates/administration & dosage , Adult , Anticholesteremic Agents/blood , Anticholesteremic Agents/pharmacokinetics , Anticholesteremic Agents/therapeutic use , Capsules , Clinical Trials as Topic , Drug Administration Schedule , Female , Fenofibrate/analogs & derivatives , Fenofibrate/blood , Fenofibrate/pharmacokinetics , Fenofibrate/therapeutic use , Humans , Hyperlipoproteinemia Type II/blood , Hypolipidemic Agents/blood , Hypolipidemic Agents/pharmacokinetics , Hypolipidemic Agents/therapeutic use , Male , Middle Aged , Patient Compliance
SELECTION OF CITATIONS
SEARCH DETAIL
...